TickerFacts.

Cytosorbents Corp (CTSO): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2016-12-31, 2018-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$38.28M
As of 2025-12-31
$38.71M
As of 2026-06-30
+11.2%
3-year compound annual growth
+29.0%
5-year compound annual growth
2010-12-31: $2.30M2011-12-31: $1.80M2012-12-31: $2.08M2013-12-31: $3.06M2015-12-31: $3.04M2016-12-31: $8.36M2017-12-31: $13.84M2018-12-31: $17.26M2019-12-31: $23.96M2020-12-31: $10.73M2021-12-31: $26.94M2022-12-31: $27.86M2023-03-31: $27.52M2023-06-30: $27.98M2023-09-30: $28.76M2023-12-31: $29.48M2024-03-31: $27.44M2024-06-30: $36.00M2024-09-30: $34.66M2024-12-31: $36.27M2025-12-31: $38.28M$38.28M
2010-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$38.28M+5.6%2026-03-30, Balance as of period end
2024-12-31$36.27Mn/a2026-03-30, Balance as of period end
2024-09-30$34.66Mn/a2025-03-31, Balance as of period end
2024-06-30$36.00Mn/a2025-03-31, Balance as of period end
2024-03-31$27.44Mn/a2025-03-31, Balance as of period end
2023-12-31$29.48Mn/a2025-03-31, Balance as of period end
2023-09-30$28.76Mn/a2025-03-31, Balance as of period end
2023-06-30$27.98Mn/a2025-03-31, Balance as of period end
2023-03-31$27.52Mn/a2025-03-31, Balance as of period end
2022-12-31$27.86M+3.4%2024-03-15, Balance as of period end
2021-12-31$26.94M+151.0%2023-03-09, Balance as of period end
2020-12-31$10.73M-55.2%2022-03-10, Balance as of period end
2019-12-31$23.96M+38.8%2021-03-09, Balance as of period end
2018-12-31$17.26Mn/c2020-03-05, Balance as of period end
2017-12-31$13.84M+65.6%2019-03-07, Balance as of period end
2016-12-31$8.36Mn/c2018-03-08, Balance as of period end
2015-12-31$3.04Mn/a2017-03-03, Balance as of period end
No annual figure between 2013-12-31 and 2015-12-31.
2013-12-31$3.06M+47.6%2014-03-31, Balance as of period end
2012-12-31$2.08M+15.1%2014-03-31, Balance as of period end
2011-12-31$1.80M-21.4%2013-04-03, Balance as of period end
2010-12-31$2.30Mn/a2012-03-30, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Cytosorbents Corp (CTSO)2025-12-31$38.28M+5.6%
ClearPoint Neuro, Inc. (CLPT)2025-12-31$69.73M+405.3%
Retractable Technologies Inc (RVP)2025-12-31$68.26M-7.2%
Utah Medical Products Inc (UTMD)2025-12-31$3.27M-35.9%
Interpace Biosciences, Inc. (IDXG)2025-12-31$11.47M-32.5%
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31$51.48M+19.1%
KORU Medical Systems, Inc. (KRMD)2025-12-31$11.15M+7.2%
SS Innovations International, Inc. (SSII)2025-12-31$36.01M+24.5%
Premier Air Charter Holdings Inc. (PREM)2025-12-31$32.08M+9.5%

Compare CTSO, CLPT, RVP, UTMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗